Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.8338
+0.0140 (1.71%)
May 6, 2026, 1:55 PM EDT - Market open
Enlivex Market Cap
Enlivex has a market cap or net worth of $200.99 million as of May 6, 2026. Its market cap has increased by 865.68% in one year.
Market Cap
200.99M
Enterprise Value
194.31M
1-Year Change
865.68%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $200.99M, an increase of 97.76%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 197.61M | 18.38% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 202.70M |
| MacroGenics | 198.94M |
| Elicio Therapeutics | 197.76M |
| Karyopharm Therapeutics | 197.70M |
| Korro Bio | 195.71M |
| Unicycive Therapeutics | 193.57M |
| Tonix Pharmaceuticals Holding | 193.19M |
| OnKure Therapeutics | 191.07M |